Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States / A. ESLER in Journal of Autism and Developmental Disorders, 49-6 (June 2019)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 49-6 (June 2019) . - p.2291-2303 Titre : Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States Type de document : Texte imprimé et/ou numérique Auteurs : A. ESLER, Auteur ; A. HEWITT, Auteur ; J. HALL-LANDE, Auteur ; S. L. PETTINGELL, Auteur ; J. HOUSEWORTH, Auteur Article en page(s) : p.2291-2303 Langues : Anglais (eng) Mots-clés : Asd  Autism spectrum disorder  Community living  Id  Intellectual and developmental disabilities  National core indicators  Psychotropic medications Index. décimale : PER Périodiques Résumé : Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD. En ligne : https://dx.doi.org/10.1007/s10803-019-03903-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=400 [article] Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States [Texte imprimé et/ou numérique] / A. ESLER, Auteur ; A. HEWITT, Auteur ; J. HALL-LANDE, Auteur ; S. L. PETTINGELL, Auteur ; J. HOUSEWORTH, Auteur . - p.2291-2303. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 49-6 (June 2019) . - p.2291-2303 Mots-clés : Asd  Autism spectrum disorder  Community living  Id  Intellectual and developmental disabilities  National core indicators  Psychotropic medications Index. décimale : PER Périodiques Résumé : Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD. En ligne : https://dx.doi.org/10.1007/s10803-019-03903-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=400

---

1 (1 - 1 / 1)